Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan (Q43850634)
Jump to navigation
Jump to search
scientific article published in November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan |
scientific article published in November 2001 |
Statements
1 reference
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan (English)
1 reference
M Dojo
1 reference
T Azuma
1 reference
T Saito
1 reference
M Ohtani
1 reference
A Muramatsu
1 reference
M Kuriyama
1 reference
1 November 2001
1 reference
1 reference
Identifiers
1 reference